glp 1 meds side effects 6 Common of Taking GLP-1 Medication GLP-1 and Low Blood Pressure:

2022;107:E133947

Hu T, Yang C, Hou Z, Liu T, Mei X, Zheng L, Zhong W

Table 2 Oxidative stress markers in normotensive, nonobese CFS patients and healthy age- and gender-matched controls CFS patients group 2 CFS patients Controls Pvalue Subject numbers n=31 n=30 Sex M:F 14:17 13:17 Age mean (range) 46 years (19 64) 45 years (19 60) Smoking Y:N:Ex 4:25:2 5:24:2 BMI (kg/m 2 ) 23.9 (3.4) 24.2 (2.8) 0.67 Cholesterol (mmol/L) 5.02 (1.1) 5.10 (0.99) 0.77 HDL (mmol/L) 1.31 (0.30) 1.60 (0.46) 0.005 OxLDL (mU/ml) 38.2 (13.8) 30.8 (10.0) 0.02 F2 a -isoprostanes (pg/ml) 406 (192) 318 (113) 0.03 GSH (Amol/L) 1284 (291) 1372 (240) 0.2 Supine systolic pressure (mm Hg) 116 (12) 118 (11) 0.48 Supine diastolic pressure (mm Hg) 70 (10) 71 (10) 0.76 Supine mean arterial pressure 85 (9.5) 87 (9) 0.59 Standing systolic pressure (mm Hg) 118 (14) 121 (15) 0.41 Standing diastolic pressure (mm Hg) 71 (12) 75 (10) 0.17 Standing mean arterial pressure 86 (11) 90 (11) 0.20 Mean [SD] using an unpaired ttest for between-group differences

Frontiers in Pharmacology, 8 , 52

However, like all medications, these are not perfect